(Q40768834)

23 September 2017

1 reference

title

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. (English)

1 reference

23 September 2017

0 references

0 references

Barnes PJ

1

1 reference

PubMed ID

8214958

23 September 2017

Pedersen S

series ordinal

2

1 reference

23 September 2017

1 October 1993

1 reference

The American Review of Respiratory Disease

23 September 2017

1 reference

23 September 2017

148

1 reference

23 September 2017

S1-26

1 reference

23 September 2017

4 Pt 2

1 reference

The steroid and thyroid hormone receptor superfamily

23 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

The glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Functional domains of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Multiple and cooperative trans-activation domains of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

The glucocorticoid domain: steroid-mediated changes in the rate of synthesis of rat hepatoma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Transcriptional analyses of steroid-regulated gene networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Genes newly identified as regulated by glucocorticoids in murine thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Identification of mRNAs associated with programmed cell death in immature thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Regulatory crosstalk at composite response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Interference of pathway specific transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Contingent genetic regulatory events in T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Regulation of Human Alveolar Macrophage- and Blood Monocyte-derived Interleukin-8 by Prostaglandin E2 and Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Corticosteroid inhibition of airway microvascular leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Pharmacologic control of plasma exudation into tracheobronchial airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Action of budesonide on asthmatic bronchial hyperresponsiveness. Effects on directly and indirectly acting bronchoconstrictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

A new approach to the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Anti-inflammatory therapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

The assessment and treatment of asthma: a conference report

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Use of inhaled corticosteroids in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

High-dose inhaled steroid therapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Inflammatory mechanisms and nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Inhaled budesonide for treatment of recurrent wheezing in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Controlled trial of budesonide given by the nebuhaler in preschool children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Asthma and irreversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Failure of Inhaled Corticosteroids to Modify Bronchoconstrictor or Bronchodilator Responsiveness in Middle-Aged Smokers with Mild Airflow Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Steroid-resistant asthma: immunologic and pharmacologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Cutaneous vasoconstrictor response to glucocorticoids in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

Circulating autoantibodies to recombinant lipocortin-1 in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.4_PT_2.S1

10.1164/AJRCCM/148.4_PT_2.S1

21 January 2018

Identifiers

DOI

0 references

PubMed ID

8214958

1 reference

PubMed ID

8214958